Karl Hörmann Selected Research

Karl Hörmann Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 07/2002
21	Squamous Cell Carcinoma of Head and Neck 05/2017 - 07/2002
9	Obstructive Sleep Apnea 11/2021 - 09/2005
8	Head and Neck Neoplasms (Head and Neck Cancer) 07/2022 - 07/2002
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2017 - 05/2013
7	Rhinosinusitis 01/2016 - 04/2008
7	Wounds and Injuries (Trauma) 12/2011 - 10/2004
6	Hereditary Hemorrhagic Telangiectasia 09/2005 - 03/2002
4	Hemorrhage 05/2017 - 03/2002
4	Snoring 03/2013 - 01/2005
3	Asthma (Bronchial Asthma) 01/2017 - 04/2008
3	Allergic Rhinitis 01/2017 - 06/2004
3	Keloid 09/2015 - 09/2010
3	Ulcer 06/2010 - 10/2004
2	Tinnitus 01/2017 - 01/2017
2	Taste Disorders (Taste Disorder) 06/2012 - 10/2010
2	Dysgeusia (Parageusia) 06/2012 - 10/2010
2	Carcinoma (Carcinomatosis) 07/2011 - 08/2003
2	Inflammation (Inflammations) 04/2008 - 06/2004
2	Epistaxis (Nosebleed) 09/2003 - 03/2002
1	Sleep Wake Disorders 11/2021
1	Apnea 11/2021
1	Dehydration (Water Stress) 05/2021
1	Malnutrition (Nutritional Deficiencies) 05/2021
1	Aspiration Pneumonia 05/2021
1	COVID-19 10/2020
1	Rhinitis 10/2020
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2014 - 07/2002
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
7	Antisense OligonucleotidesIBA 07/2011 - 07/2002
6	Pharmaceutical PreparationsIBA 01/2019 - 10/2004
6	CytokinesIBA 01/2016 - 02/2004
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 10/2004
5	Messenger RNA (mRNA)IBA 07/2011 - 07/2002
4	Tyrosine Kinase InhibitorsIBA 05/2017 - 12/2013
4	Matrix Metalloproteinases (MMPs)IBA 09/2014 - 03/2005
4	Conditioned Culture MediaIBA 07/2011 - 07/2002
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2017 - 12/2013
3	TOR Serine-Threonine KinasesIBA 04/2015 - 12/2013
3	Everolimus FDA Link 04/2015 - 12/2013
3	Sorafenib (BAY 43-9006)FDA Link 04/2015 - 12/2013
3	Sunitinib (Sutent)FDA Link 04/2015 - 12/2013
3	Platelet-Derived Growth FactorIBA 09/2014 - 01/2009
3	Fluorouracil (Carac)FDA LinkGeneric 09/2014 - 05/2013
3	Interleukin-6 (Interleukin 6)IBA 09/2014 - 07/2005
3	PlatinumIBA 09/2014 - 05/2013
3	Interleukin-5 (Interleukin 5)IBA 07/2014 - 07/2008
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2013 - 01/2009
3	Estriol (Epiestriol)IBA 09/2005 - 03/2002
2	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 07/2004
2	nilotinib FDA Link 05/2017 - 06/2016
2	Dasatinib (BMS 354825)FDA Link 05/2017 - 06/2016
2	Gefitinib (Iressa)FDA Link 05/2017 - 06/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2017 - 06/2016
2	Indicators and Reagents (Reagents)IBA 01/2017 - 05/2009
2	AllergensIBA 01/2017 - 06/2004
2	Immunoglobulin E (IgE)IBA 01/2017 - 06/2004
2	EnzymesIBA 06/2016 - 09/2014
2	ImmunosorbentsIBA 06/2016 - 09/2014
2	Phosphotransferases (Kinase)IBA 04/2015 - 04/2011
2	Biomarkers (Surrogate Marker)IBA 09/2014 - 07/2005
2	Angiogenic ProteinsIBA 09/2014 - 05/2013
2	ErbB Receptors (EGF Receptor)IBA 09/2014 - 07/2002
2	Docetaxel (Taxotere)FDA Link 09/2014 - 05/2013
2	Carboplatin (JM8)FDA LinkGeneric 04/2011 - 07/2004
2	Imatinib Mesylate (Gleevec)FDA Link 04/2011 - 01/2009
2	Transforming Growth Factor alpha (TGF-alpha)IBA 06/2010 - 03/2007
2	beta CateninIBA 04/2008 - 01/2003
2	SuspensionsIBA 05/2006 - 09/2005
2	Biological ProductsIBA 07/2005 - 02/2004
2	Interleukin-8 (Interleukin 8)IBA 04/2005 - 03/2005
2	Collagenases (Collagenase)FDA Link 03/2005 - 10/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 02/2005 - 10/2004
2	OligonucleotidesIBA 01/2005 - 09/2003
1	Oxygen (Dioxygen)IBA 11/2021
1	Irritants (Vesicants)IBA 10/2020
1	Exonucleases (3' 5' Exonuclease)IBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2017
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 05/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	CateninsIBA 01/2017
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2016
1	OligodeoxyribonucleotidesIBA 01/2016
1	AmphiregulinIBA 04/2015

Therapy/Procedure

19	Therapeutics 01/2019 - 07/2002
5	Tonsillectomy 05/2017 - 10/2010
4	Continuous Positive Airway Pressure 01/2017 - 05/2006
4	Drug Therapy (Chemotherapy) 09/2014 - 07/2004
3	Aftercare (After-Treatment) 03/2007 - 03/2002
2	Induction Chemotherapy 09/2014 - 05/2013
2	Argon Plasma Coagulation 09/2003 - 03/2002
1	Long-Term Care 05/2021
1	Personal Protective Equipment 10/2020
1	Mechanical Ventilators (Ventilator) 10/2020
1	Hearing Aids (Hearing Aid) 01/2017
1	Cochlear Implantation 01/2017
1	Cochlear Implants (Cochlear Implant) 01/2017
1	Splints (Splint) 09/2015